Pillstats
Rx only · Tablet · Oral

Lovastatin

Lovastatin

17 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US72 NDCs
17 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)6472
US makers17 labelers
Packages196
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 31 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.014$0.027$0.041$0.055Dec 2025Apr 2026Jul 2026
$0.047
Latest avg · Jul 22, 2026
-2%
Since Dec 17, 2025
17
Active US suppliers
40%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

24K47K71K94K2025 Q12025 Q22025 Q32025 Q42026 Q1
58K
Rx · 2026 Q1
3.1M
Units dispensed
-29%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it17 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager39SUPPLYING
Proficient Rx LPunknown39SUPPLYING
Preferred Pharmaceuticals Inc.unknown17SUPPLYING
PD-Rx Pharmaceuticals, Inc.unknown14SUPPLYING
NuCare Pharmaceuticals, Inc.unknown13SUPPLYING
A-S Medication Solutionsunknown12SUPPLYING
Carlsbad Technology, Inc.unknown12SUPPLYING
Lupin Pharmaceuticals,Inc.unknown12SUPPLYING
Aphena Pharma Solutions - Tennessee, LLCunknown6SUPPLYING
Teva Pharmaceuticals USA, Inc.unknown6SUPPLYING
Northwind Health Company, LLCunknown6SUPPLYING
BluePoint Laboratoriesunknown6SUPPLYING
REMEDYREPACK INC.repackager5SUPPLYING
Golden State Medical Supply, Inc.unknown3SUPPLYING
Boswell Pharmacy Services LLC d/b/a BPS Wholesaleunknown2SUPPLYING

+ 2 more labelers

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Feb 19, 2019
    RECALLRecall (Class III): Lovastatin Tablets USP, 40 mg, packaged in a) 100-count bottles (NDC 68001-316-00) and b)1000-count bottles (NDC 68001-…

    CGMP Deviations: Finished product made with lovastatin drug substance that was out of specification for individual impurity results. — Recalling firm: American Health Packaging — Nationwide within the USA and Puerto Rico

  • Feb 13, 2019
    RECALLRecall (Class III): Lovastatin Tablets USP, 40 mg, packaged in a) 60-count (NDC 68180-469-07 and b) 100-count (NDC 68180-469-01) bottles, R…

    CGMP Deviations: Finished product made with lovastatin drug substance that was out of specification for individual impurity results. — Recalling firm: Lupin Pharmaceuticals Inc. — Nationwide in the USA and Puerto Rico.